Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Daniel Pollyea

Concepts (484)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Leukemia, Myeloid, Acute
118
2026
682
26.250
 Why?
Bridged Bicyclo Compounds, Heterocyclic
42
2026
279
10.660
 Why?
Sulfonamides
42
2026
580
9.300
 Why?
Antineoplastic Combined Chemotherapy Protocols
51
2026
1953
7.670
 Why?
Myelodysplastic Syndromes
30
2026
147
6.940
 Why?
Azacitidine
24
2026
156
6.370
 Why?
Antineoplastic Agents
26
2026
2192
3.440
 Why?
Mutation
37
2026
4085
3.040
 Why?
Isocitrate Dehydrogenase
13
2022
70
2.800
 Why?
Hematologic Neoplasms
10
2023
161
2.650
 Why?
Neoplasm, Residual
8
2026
139
2.400
 Why?
Neoplastic Stem Cells
15
2025
412
2.310
 Why?
Hematopoietic Stem Cell Transplantation
17
2024
674
2.140
 Why?
Triazines
7
2021
49
1.850
 Why?
Aminopyridines
7
2021
127
1.780
 Why?
Remission Induction
16
2026
306
1.670
 Why?
Graft vs Host Disease
9
2024
264
1.610
 Why?
Neoplasm Recurrence, Local
6
2025
1137
1.610
 Why?
Prognosis
30
2026
4278
1.580
 Why?
RNA Splicing Factors
3
2020
64
1.360
 Why?
Humans
164
2026
144261
1.350
 Why?
Aged
63
2026
25850
1.330
 Why?
Aged, 80 and over
34
2025
8243
1.310
 Why?
Phosphoproteins
3
2020
343
1.180
 Why?
Cytarabine
8
2022
66
1.170
 Why?
Treatment Outcome
35
2026
11643
1.120
 Why?
Leukemia
4
2023
245
1.060
 Why?
Immunotherapy, Adoptive
3
2025
337
0.960
 Why?
Salvage Therapy
5
2023
162
0.950
 Why?
Clonal Evolution
2
2017
47
0.930
 Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2025
7
0.930
 Why?
Cord Blood Stem Cell Transplantation
4
2024
103
0.920
 Why?
Middle Aged
51
2026
35762
0.910
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
2
2022
76
0.850
 Why?
fms-Like Tyrosine Kinase 3
4
2017
49
0.840
 Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
2023
293
0.830
 Why?
Histocompatibility Antigens Class I
1
2025
202
0.820
 Why?
Drug Resistance, Neoplasm
9
2025
881
0.820
 Why?
Nuclear Proteins
5
2018
748
0.820
 Why?
Molecular Targeted Therapy
7
2024
431
0.790
 Why?
Carrier Proteins
3
2017
736
0.780
 Why?
Transplantation Conditioning
9
2024
186
0.780
 Why?
Leukemia, Neutrophilic, Chronic
3
2019
5
0.770
 Why?
Thrombocytopenia
2
2023
205
0.740
 Why?
Spliceosomes
2
2020
51
0.730
 Why?
Dancing
1
2022
19
0.730
 Why?
Male
61
2026
72035
0.720
 Why?
Proto-Oncogene Proteins c-bcl-2
4
2018
240
0.700
 Why?
Female
66
2026
77976
0.700
 Why?
Enzyme Inhibitors
5
2020
824
0.700
 Why?
Anemia
2
2020
187
0.690
 Why?
Febrile Neutropenia
1
2020
6
0.670
 Why?
Adult
37
2025
40262
0.660
 Why?
Splicing Factor U2AF
2
2023
18
0.640
 Why?
T-Lymphocytes
2
2025
1982
0.610
 Why?
Receptors, Colony-Stimulating Factor
2
2017
7
0.610
 Why?
Serine-Arginine Splicing Factors
2
2019
26
0.610
 Why?
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
6
2025
127
0.600
 Why?
Phenylurea Compounds
7
2020
112
0.560
 Why?
DNA Methylation
3
2019
681
0.560
 Why?
Staurosporine
1
2017
22
0.540
 Why?
Stem Cells
3
2020
625
0.530
 Why?
Benzimidazoles
6
2020
190
0.510
 Why?
Gene Frequency
2
2017
481
0.490
 Why?
Protein Kinase Inhibitors
10
2025
968
0.480
 Why?
Monocytes
2
2018
538
0.470
 Why?
Neoplasms, Plasma Cell
1
2015
5
0.470
 Why?
Recurrence
9
2023
1134
0.470
 Why?
Leukocytosis
1
2015
32
0.470
 Why?
Skin Neoplasms
1
2023
847
0.460
 Why?
Signal Transduction
10
2025
5221
0.460
 Why?
Glycine
4
2021
187
0.460
 Why?
Gene Expression
1
2020
1487
0.460
 Why?
High-Throughput Nucleotide Sequencing
2
2018
549
0.460
 Why?
Epigenesis, Genetic
1
2019
684
0.430
 Why?
Maximum Tolerated Dose
5
2019
212
0.420
 Why?
Precision Medicine
1
2018
456
0.420
 Why?
Retrospective Studies
16
2024
17009
0.420
 Why?
Oxidative Phosphorylation
6
2024
210
0.420
 Why?
Patient Safety
1
2018
347
0.410
 Why?
Computational Biology
1
2019
680
0.410
 Why?
Clinical Trials, Phase I as Topic
2
2024
52
0.410
 Why?
Apoptosis
4
2018
2430
0.400
 Why?
Induction Chemotherapy
3
2024
87
0.400
 Why?
Pyridines
5
2023
605
0.400
 Why?
Medical Oncology
4
2023
331
0.400
 Why?
Clinical Trials, Phase III as Topic
2
2024
117
0.400
 Why?
Hematopoiesis
4
2020
194
0.400
 Why?
Neoplasm Proteins
4
2022
442
0.400
 Why?
Neoplasms
5
2025
2870
0.390
 Why?
Pyrazoles
1
2017
509
0.380
 Why?
Dose-Response Relationship, Drug
7
2021
2026
0.380
 Why?
Germ-Line Mutation
3
2022
172
0.380
 Why?
Immunity, Innate
1
2019
846
0.380
 Why?
Mitochondria
4
2025
983
0.380
 Why?
Leukemia, Myeloid
1
2012
48
0.380
 Why?
Glutarates
1
2012
11
0.370
 Why?
DNA (Cytosine-5-)-Methyltransferases
2
2018
37
0.360
 Why?
STAT3 Transcription Factor
2
2025
207
0.360
 Why?
Biomarkers, Tumor
5
2025
1313
0.350
 Why?
Survival Rate
11
2025
2088
0.350
 Why?
RNA Splicing
4
2023
284
0.340
 Why?
Young Adult
16
2025
13990
0.340
 Why?
Neutrophils
2
2023
1134
0.340
 Why?
United States Food and Drug Administration
2
2022
203
0.330
 Why?
Follow-Up Studies
8
2020
5389
0.330
 Why?
Drug Delivery Systems
1
2014
379
0.330
 Why?
Aldehyde Dehydrogenase
3
2017
99
0.320
 Why?
Antibodies, Monoclonal, Humanized
7
2023
985
0.320
 Why?
Leukocyte Count
2
2024
316
0.320
 Why?
Rhipicephalus sanguineus
1
2009
1
0.310
 Why?
Triatoma
1
2009
7
0.310
 Why?
Insect Bites and Stings
1
2009
13
0.310
 Why?
Wasps
1
2009
23
0.300
 Why?
Syncope
1
2009
55
0.300
 Why?
Cytokines
4
2020
2061
0.290
 Why?
Electron Transport Complex II
2
2019
28
0.290
 Why?
Mutant Proteins
2
2019
106
0.280
 Why?
Kaplan-Meier Estimate
5
2020
964
0.280
 Why?
Proto-Oncogene Proteins
2
2018
623
0.280
 Why?
Cell Self Renewal
2
2019
53
0.280
 Why?
Influenza A Virus, H1N1 Subtype
1
2010
157
0.280
 Why?
Anaphylaxis
1
2009
102
0.280
 Why?
Risk Assessment
5
2024
3637
0.280
 Why?
Acute Disease
3
2023
1028
0.280
 Why?
Administration, Oral
4
2018
847
0.280
 Why?
Bone Marrow
4
2017
304
0.270
 Why?
Transplantation, Homologous
6
2022
415
0.270
 Why?
Randomized Controlled Trials as Topic
3
2024
1705
0.260
 Why?
Gene Expression Regulation, Leukemic
3
2016
56
0.260
 Why?
Survival Analysis
6
2020
1382
0.260
 Why?
Drug Administration Schedule
4
2020
778
0.260
 Why?
Animals
28
2026
38030
0.250
 Why?
Disease-Free Survival
5
2022
768
0.250
 Why?
Mice
20
2026
18329
0.250
 Why?
Thrombocythemia, Essential
2
2016
6
0.240
 Why?
Polycythemia Vera
2
2016
8
0.240
 Why?
Primary Myelofibrosis
2
2016
8
0.240
 Why?
Cytogenetic Analysis
2
2022
33
0.230
 Why?
Voltage-Dependent Anion Channel 1
1
2025
15
0.230
 Why?
Hematopoietic Cell Growth Factors
1
2025
5
0.230
 Why?
Clinical Trials as Topic
4
2020
1050
0.230
 Why?
Hematopoietic Stem Cells
3
2022
420
0.230
 Why?
Influenza Vaccines
1
2010
529
0.220
 Why?
Phenotype
3
2025
3157
0.220
 Why?
DEAD-box RNA Helicases
2
2015
90
0.220
 Why?
Transplantation, Haploidentical
1
2024
23
0.210
 Why?
Granulocyte-Macrophage Colony-Stimulating Factor
1
2025
161
0.210
 Why?
Stem Cell Transplantation
3
2023
191
0.200
 Why?
Influenza, Human
1
2010
615
0.200
 Why?
Azetidines
1
2024
44
0.200
 Why?
Allografts
2
2021
150
0.200
 Why?
Finland
1
2023
79
0.200
 Why?
DNA Mutational Analysis
4
2019
405
0.200
 Why?
Time-to-Treatment
1
2025
240
0.200
 Why?
Down-Regulation
1
2025
627
0.190
 Why?
Drug Therapy, Combination
4
2022
1044
0.190
 Why?
DNA-Binding Proteins
1
2010
1497
0.190
 Why?
Antibodies, Neoplasm
3
2007
34
0.190
 Why?
Antibodies, Monoclonal
4
2017
1519
0.190
 Why?
Disease Management
4
2021
643
0.190
 Why?
Uncertainty
1
2023
144
0.190
 Why?
Interleukin-3 Receptor alpha Subunit
2
2019
17
0.190
 Why?
RNA, Messenger
1
2010
2829
0.180
 Why?
Myeloproliferative Disorders
1
2022
19
0.180
 Why?
Hematology
1
2022
21
0.180
 Why?
Piperidines
1
2024
217
0.180
 Why?
Amino Acid Transport System ASC
1
2022
12
0.180
 Why?
Thalidomide
2
2012
43
0.180
 Why?
Proto-Oncogene Proteins c-myc
2
2022
167
0.180
 Why?
Succinate Dehydrogenase
2
2019
57
0.180
 Why?
Calcium
2
2025
1182
0.180
 Why?
Minor Histocompatibility Antigens
1
2022
47
0.180
 Why?
Lymphoma, Non-Hodgkin
1
2023
124
0.180
 Why?
Disease Progression
3
2023
2840
0.170
 Why?
Receptors, Mitogen
1
2021
7
0.170
 Why?
Cell Line, Tumor
8
2025
3539
0.170
 Why?
Polymerase Chain Reaction
1
2024
1054
0.170
 Why?
Lectins, C-Type
1
2021
62
0.170
 Why?
Blood Cell Count
1
2020
54
0.170
 Why?
Erythroblasts
1
2020
19
0.160
 Why?
Lipids
1
2025
700
0.160
 Why?
Cell Transformation, Neoplastic
3
2018
339
0.160
 Why?
Inflammation Mediators
2
2020
508
0.160
 Why?
Histocompatibility Testing
2
2019
121
0.160
 Why?
Lipase
1
2020
74
0.160
 Why?
Tumor Lysis Syndrome
1
2019
9
0.150
 Why?
United States
6
2025
15876
0.150
 Why?
Cell Survival
5
2025
1098
0.150
 Why?
Dendritic Cells
1
2023
499
0.150
 Why?
Chemical and Drug Induced Liver Injury
1
2021
139
0.150
 Why?
Immunoconjugates
1
2021
132
0.150
 Why?
Leukopoiesis
1
2019
11
0.150
 Why?
Myeloid Progenitor Cells
1
2019
17
0.150
 Why?
NADPH Oxidase 2
1
2019
35
0.150
 Why?
NF-kappa B p50 Subunit
1
2019
22
0.150
 Why?
Fatty Acids
2
2020
450
0.150
 Why?
RAW 264.7 Cells
1
2019
50
0.150
 Why?
K562 Cells
1
2019
93
0.150
 Why?
Age Factors
5
2022
3313
0.150
 Why?
Tricarboxylic Acids
1
2018
11
0.150
 Why?
Genetic Testing
2
2019
478
0.140
 Why?
Ketoglutaric Acids
1
2018
23
0.140
 Why?
Hematologic Diseases
1
2019
66
0.140
 Why?
Mycoses
1
2019
88
0.140
 Why?
Antibodies
1
2021
401
0.140
 Why?
Tumor Suppressor Protein p53
1
2022
529
0.140
 Why?
Genomics
3
2019
833
0.140
 Why?
Mitochondrial Proteins
2
2018
261
0.140
 Why?
Thiotepa
1
2018
21
0.140
 Why?
Antibiotic Prophylaxis
1
2019
129
0.140
 Why?
Macrophages
1
2026
1510
0.140
 Why?
Antimetabolites, Antineoplastic
1
2018
105
0.140
 Why?
Amino Acids
2
2020
521
0.140
 Why?
Trees
1
2018
67
0.140
 Why?
Cysteine
1
2019
210
0.130
 Why?
Lymphoma
2
2017
232
0.130
 Why?
Fusion Proteins, bcr-abl
2
2014
69
0.130
 Why?
HLA-DR Antigens
1
2018
220
0.130
 Why?
Confidence Intervals
1
2018
333
0.130
 Why?
Hematinics
1
2017
22
0.130
 Why?
Mediastinal Neoplasms
1
2017
51
0.130
 Why?
AMP-Activated Protein Kinases
1
2018
190
0.120
 Why?
Infusions, Intravenous
1
2018
423
0.120
 Why?
Hedgehog Proteins
1
2018
197
0.120
 Why?
Periodicals as Topic
1
2019
203
0.120
 Why?
Ataxia Telangiectasia Mutated Proteins
1
2016
69
0.120
 Why?
Unrelated Donors
1
2016
38
0.120
 Why?
Registries
3
2025
2382
0.120
 Why?
Genome, Human
1
2018
422
0.120
 Why?
Cohort Studies
5
2022
5935
0.120
 Why?
Glucosephosphate Dehydrogenase
1
2016
69
0.120
 Why?
Geriatric Assessment
1
2018
231
0.120
 Why?
Energy Metabolism
2
2019
935
0.120
 Why?
Pyrimidines
2
2017
532
0.120
 Why?
NF-E2-Related Factor 2
1
2016
95
0.120
 Why?
Oncogene Proteins
1
2016
61
0.120
 Why?
Nitriles
1
2017
205
0.120
 Why?
Receptor-Interacting Protein Serine-Threonine Kinases
1
2015
14
0.110
 Why?
Mice, Inbred NOD
4
2019
610
0.110
 Why?
Methyltransferases
1
2016
74
0.110
 Why?
Genetic Predisposition to Disease
2
2022
2359
0.110
 Why?
Lipopolysaccharides
1
2019
863
0.110
 Why?
Myeloid-Lymphoid Leukemia Protein
1
2016
72
0.110
 Why?
Biomarkers
3
2022
4254
0.110
 Why?
Programmed Cell Death 1 Receptor
1
2017
264
0.110
 Why?
Oligomycins
1
2014
7
0.110
 Why?
Chromosome Aberrations
1
2015
162
0.110
 Why?
Hemoglobins
2
2018
383
0.110
 Why?
Mitochondrial Proton-Translocating ATPases
1
2014
23
0.110
 Why?
Adolescent
7
2024
22281
0.110
 Why?
In Situ Hybridization, Fluorescence
1
2015
322
0.110
 Why?
Electronic Health Records
1
2023
1169
0.110
 Why?
Homeostasis
1
2018
640
0.110
 Why?
Calcineurin Inhibitors
1
2014
69
0.100
 Why?
Necrosis
1
2015
244
0.100
 Why?
Histone-Lysine N-Methyltransferase
1
2016
141
0.100
 Why?
Cells, Cultured
5
2019
4146
0.100
 Why?
Vidarabine
2
2018
32
0.100
 Why?
Harringtonines
1
2013
2
0.100
 Why?
Tumor Suppressor Proteins
1
2016
321
0.100
 Why?
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
2013
1
0.100
 Why?
Predictive Value of Tests
1
2019
2111
0.100
 Why?
Alemtuzumab
3
2007
15
0.100
 Why?
Interleukin-1
1
2017
961
0.100
 Why?
Glucose
1
2018
1046
0.100
 Why?
Gene Expression Profiling
3
2019
1782
0.100
 Why?
Pyridazines
1
2013
57
0.090
 Why?
Carbon Monoxide
1
2013
82
0.090
 Why?
Nausea
1
2012
111
0.090
 Why?
5-Methylcytosine
1
2012
25
0.090
 Why?
Gene Expression Regulation, Neoplastic
1
2018
1455
0.090
 Why?
Biopsy
1
2015
1075
0.090
 Why?
Vomiting
1
2012
130
0.090
 Why?
Liver
1
2020
1884
0.090
 Why?
Membrane Proteins
1
2018
1165
0.090
 Why?
Imidazoles
1
2013
254
0.090
 Why?
Core Binding Factor Alpha 2 Subunit
2
2023
30
0.080
 Why?
Incidence
2
2016
2870
0.080
 Why?
Amino Acid Sequence
2
2015
2154
0.080
 Why?
Sesquiterpenes
2
2016
52
0.080
 Why?
Dioxygenases
1
2010
36
0.080
 Why?
Oxidants
1
2011
103
0.080
 Why?
Fatigue
1
2012
361
0.080
 Why?
Length of Stay
1
2016
1335
0.080
 Why?
GTP-Binding Proteins
1
2011
153
0.080
 Why?
Software
1
2015
690
0.080
 Why?
Chronic Disease
1
2016
1812
0.080
 Why?
Wasp Venoms
1
2009
4
0.080
 Why?
Insulin Resistance
1
2018
1232
0.080
 Why?
Ethanol
1
2015
625
0.080
 Why?
Blast Crisis
2
2025
35
0.080
 Why?
Protein Multimerization
1
2011
213
0.080
 Why?
Injections, Subcutaneous
1
2009
164
0.080
 Why?
Hydrogen Peroxide
1
2011
336
0.070
 Why?
Epinephrine
1
2009
155
0.070
 Why?
Mice, Transgenic
3
2023
2182
0.070
 Why?
Immunization Schedule
1
2010
187
0.070
 Why?
Emergencies
1
2009
175
0.070
 Why?
Adjuvants, Immunologic
1
2010
245
0.070
 Why?
RNA, Small Interfering
3
2016
634
0.070
 Why?
Melphalan
1
2007
42
0.070
 Why?
Inflammation
1
2019
2877
0.070
 Why?
Phosphorylation
2
2025
1732
0.060
 Why?
Transplantation Chimera
1
2007
56
0.060
 Why?
Tumor Cells, Cultured
2
2022
919
0.060
 Why?
Karnofsky Performance Status
1
2006
37
0.060
 Why?
Blood Transfusion
2
2020
405
0.060
 Why?
HEK293 Cells
2
2019
744
0.060
 Why?
Cell Differentiation
2
2026
2048
0.060
 Why?
Disease Models, Animal
3
2026
4556
0.060
 Why?
Protein-Tyrosine Kinases
3
2014
433
0.060
 Why?
Receptors, Thrombopoietin
2
2016
6
0.060
 Why?
Mice, Inbred C57BL
4
2020
5988
0.060
 Why?
Calreticulin
2
2016
22
0.060
 Why?
Janus Kinase 2
2
2016
29
0.060
 Why?
Evidence-Based Medicine
1
2010
729
0.060
 Why?
Exome
2
2018
227
0.060
 Why?
Ganciclovir
1
2006
53
0.060
 Why?
Valine
1
2006
80
0.060
 Why?
Acyclovir
1
2006
96
0.060
 Why?
Philadelphia Chromosome
2
2016
18
0.060
 Why?
Cell Proliferation
3
2020
2494
0.050
 Why?
Granulocyte Colony-Stimulating Factor
1
2025
89
0.050
 Why?
Risk Factors
3
2014
10699
0.050
 Why?
Bone Marrow Transplantation
1
2006
294
0.050
 Why?
Phagocytosis
1
2026
299
0.050
 Why?
Pedigree
2
2015
513
0.050
 Why?
Janus Kinases
2
2015
20
0.050
 Why?
Oxidation-Reduction
2
2019
1084
0.050
 Why?
Cytomegalovirus Infections
1
2006
206
0.050
 Why?
Diamines
1
2023
5
0.050
 Why?
Antigens, CD34
1
2023
88
0.050
 Why?
para-Aminobenzoates
1
2023
8
0.050
 Why?
Chemotaxis
1
2023
122
0.050
 Why?
Xenograft Model Antitumor Assays
2
2016
928
0.050
 Why?
Flow Cytometry
2
2018
1172
0.050
 Why?
Aniline Compounds
1
2023
119
0.050
 Why?
Angiogenesis Inhibitors
1
2004
236
0.050
 Why?
Breast Neoplasms
1
2015
2447
0.050
 Why?
Pyrrolidines
1
2023
125
0.050
 Why?
Practice Guidelines as Topic
1
2010
1559
0.040
 Why?
Neutropenia
1
2022
155
0.040
 Why?
Drug Interactions
2
2013
397
0.040
 Why?
Recombinant Proteins
1
2025
1367
0.040
 Why?
Benzodiazepines
1
2023
165
0.040
 Why?
Early Termination of Clinical Trials
1
2021
18
0.040
 Why?
Quinuclidines
1
2020
11
0.040
 Why?
Clinical Trials, Phase II as Topic
1
2020
77
0.040
 Why?
Hyperbilirubinemia
1
2020
11
0.040
 Why?
Receptors, Cell Surface
1
2022
377
0.040
 Why?
Niacinamide
1
2020
86
0.040
 Why?
Neoplasms, Second Primary
1
2021
100
0.040
 Why?
Antiviral Agents
1
2006
767
0.040
 Why?
Machine Learning
1
2025
585
0.040
 Why?
Proportional Hazards Models
2
2017
1322
0.040
 Why?
Lentivirus
1
2019
60
0.040
 Why?
Disease Susceptibility
1
2021
346
0.040
 Why?
Mice, Nude
2
2015
682
0.040
 Why?
Daunorubicin
1
2018
25
0.040
 Why?
Consolidation Chemotherapy
1
2018
10
0.040
 Why?
Multicenter Studies as Topic
1
2020
402
0.040
 Why?
Maintenance Chemotherapy
1
2018
42
0.040
 Why?
Myeloablative Agonists
1
2018
23
0.030
 Why?
Mice, SCID
1
2019
369
0.030
 Why?
Datasets as Topic
1
2018
122
0.030
 Why?
Mice, Knockout
2
2016
3119
0.030
 Why?
Forkhead Transcription Factors
1
2019
202
0.030
 Why?
Iron
1
2020
359
0.030
 Why?
Cause of Death
1
2020
464
0.030
 Why?
HLA Antigens
1
2019
225
0.030
 Why?
Whole-Body Irradiation
1
2018
76
0.030
 Why?
Fetal Blood
1
2020
342
0.030
 Why?
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor
1
2017
16
0.030
 Why?
Cell Count
1
2018
320
0.030
 Why?
Antineoplastic Agents, Immunological
1
2020
199
0.030
 Why?
Biological Transport
1
2018
412
0.030
 Why?
Clinical Decision-Making
1
2021
358
0.030
 Why?
Child
2
2024
22537
0.030
 Why?
Tumor Stem Cell Assay
1
2017
34
0.030
 Why?
Glutathione
1
2019
375
0.030
 Why?
Retinal Dehydrogenase
1
2017
29
0.030
 Why?
Combined Modality Therapy
1
2020
1264
0.030
 Why?
Diet, High-Fat
1
2018
261
0.030
 Why?
Arsenicals
1
2017
28
0.030
 Why?
Oxides
1
2017
51
0.030
 Why?
Glycolysis
1
2018
339
0.030
 Why?
Benzothiazoles
1
2016
40
0.030
 Why?
NADP
1
2016
55
0.030
 Why?
Heterografts
1
2017
143
0.030
 Why?
Hydrazines
1
2016
37
0.030
 Why?
Adenosine Triphosphate
1
2019
498
0.030
 Why?
Cyclophosphamide
1
2017
266
0.030
 Why?
Drug Monitoring
1
2020
389
0.030
 Why?
Myeloid Ecotropic Viral Integration Site 1 Protein
1
2016
11
0.030
 Why?
Deoxyglucose
1
2016
51
0.030
 Why?
Receptors, Interleukin-1
1
2017
213
0.030
 Why?
Sample Size
1
2016
123
0.030
 Why?
Kinetics
1
2019
1627
0.030
 Why?
Reactive Oxygen Species
1
2019
621
0.030
 Why?
Drug Combinations
1
2017
390
0.030
 Why?
Tumor Microenvironment
1
2020
732
0.030
 Why?
Sequence Analysis, RNA
1
2018
442
0.030
 Why?
p38 Mitogen-Activated Protein Kinases
1
2017
266
0.030
 Why?
Isoenzymes
1
2016
299
0.030
 Why?
Transcriptome
1
2022
1044
0.030
 Why?
Positron-Emission Tomography
1
2017
323
0.030
 Why?
Splenomegaly
1
2015
14
0.030
 Why?
Intercellular Signaling Peptides and Proteins
1
2017
381
0.030
 Why?
Colorado
1
2025
4562
0.030
 Why?
Phosphatidylinositol 3-Kinases
1
2017
379
0.030
 Why?
Dihydrolipoyllysine-Residue Acetyltransferase
1
2014
6
0.030
 Why?
Ketone Oxidoreductases
1
2014
7
0.030
 Why?
Hydroxyurea
1
2015
34
0.030
 Why?
Repressor Proteins
1
2018
437
0.030
 Why?
Lipid Metabolism
1
2018
525
0.030
 Why?
Diagnosis, Differential
1
2019
1487
0.030
 Why?
Metabolome
1
2018
384
0.030
 Why?
Comorbidity
2
2013
1646
0.030
 Why?
Fluorescent Antibody Technique
1
2015
370
0.030
 Why?
Interleukin-1beta
1
2017
395
0.030
 Why?
Membrane Potential, Mitochondrial
1
2014
75
0.030
 Why?
Imatinib Mesylate
1
2014
77
0.030
 Why?
Sirolimus
1
2016
281
0.030
 Why?
Health Services Accessibility
1
2023
1091
0.030
 Why?
Immunologic Factors
1
2017
255
0.030
 Why?
Sequence Homology, Amino Acid
1
2015
396
0.030
 Why?
Superoxides
1
2014
204
0.030
 Why?
Dasatinib
1
2014
57
0.030
 Why?
Quality of Life
2
2016
3166
0.030
 Why?
Age of Onset
1
2015
536
0.030
 Why?
Structure-Activity Relationship
1
2015
567
0.030
 Why?
Thiazoles
1
2014
135
0.030
 Why?
Genetic Heterogeneity
1
2014
62
0.030
 Why?
Research Design
1
2020
1129
0.020
 Why?
Leukemia, Lymphoid
1
2013
27
0.020
 Why?
Drug Synergism
1
2014
357
0.020
 Why?
Trans-Activators
1
2016
405
0.020
 Why?
Up-Regulation
1
2016
851
0.020
 Why?
Cyclosporine
1
2014
265
0.020
 Why?
Pulmonary Diffusing Capacity
1
2013
78
0.020
 Why?
RNA Interference
1
2014
476
0.020
 Why?
Polymorphism, Single Nucleotide
1
2020
2143
0.020
 Why?
Mice, Inbred BALB C
1
2015
1253
0.020
 Why?
Homeodomain Proteins
1
2016
523
0.020
 Why?
Cost-Benefit Analysis
1
2015
623
0.020
 Why?
Leupeptins
1
2011
12
0.020
 Why?
HL-60 Cells
1
2011
29
0.020
 Why?
Thrombosis
1
2015
393
0.020
 Why?
Respiratory Function Tests
1
2013
546
0.020
 Why?
Proteasome Inhibitors
1
2011
40
0.020
 Why?
Cysteine Proteinase Inhibitors
1
2011
50
0.020
 Why?
Mitoxantrone
1
2010
15
0.020
 Why?
Free Radical Scavengers
1
2011
81
0.020
 Why?
Genotype
1
2015
1833
0.020
 Why?
Molecular Sequence Data
1
2015
2929
0.020
 Why?
Etoposide
1
2010
166
0.020
 Why?
Acetylcysteine
1
2011
138
0.020
 Why?
Neoplasms, Experimental
1
2011
173
0.020
 Why?
Mutagenesis, Site-Directed
1
2011
381
0.020
 Why?
Proteasome Endopeptidase Complex
1
2011
159
0.020
 Why?
Prospective Studies
2
2016
7970
0.020
 Why?
Treatment Failure
1
2010
363
0.020
 Why?
Prevalence
1
2016
2815
0.020
 Why?
Models, Biological
1
2017
1820
0.020
 Why?
Insulin
1
2018
2501
0.020
 Why?
RNA-Binding Proteins
1
2011
462
0.020
 Why?
Nitroimidazoles
1
2004
16
0.010
 Why?
Cyclohexanes
1
2004
23
0.010
 Why?
Fluorescein
1
2004
24
0.010
 Why?
In Situ Nick-End Labeling
1
2004
121
0.010
 Why?
Radiation-Sensitizing Agents
1
2004
43
0.010
 Why?
Lectins
1
2004
44
0.010
 Why?
Neoplasm Transplantation
1
2004
251
0.010
 Why?
Microcirculation
1
2004
138
0.010
 Why?
In Situ Hybridization
1
2004
319
0.010
 Why?
Angiography
1
2004
207
0.010
 Why?
Antibiotics, Antineoplastic
1
2004
139
0.010
 Why?
Capillaries
1
2004
124
0.010
 Why?
Wilms Tumor
1
2004
85
0.010
 Why?
Neovascularization, Pathologic
1
2004
286
0.010
 Why?
Vascular Endothelial Growth Factor A
1
2004
557
0.010
 Why?
Immunohistochemistry
1
2004
1715
0.010
 Why?
Hypoxia
1
2004
1199
0.010
 Why?
Pollyea's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (484) concept(s)
_
Co-Authors Expand Description
See all (72) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)